RN7SKP4

Across TCGA pan-cancer cohorts, RN7SKP4 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of RN7SKP4’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where RN7SKP4 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RN7SKP4 is over-expressed in tumor, although a few such as HNSC and THCA show the opposite, repressed pattern.

STAD, HNSC, and COAD are the cancer types where RN7SKP4 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SKP4 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	Male	All	+0.148	.008	3	view →
HNSC	Female	III,IV	−0.093	.026	3	view →
COAD	All	All	+0.078	.029	2	view →
HNSC	Male	All	+0.060	.023	2	view →
THCA	All	All	−0.021	.045	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 4 lineages.

RN7SKP4–STAD

Open the STAD breakdown →